POMALYST owner Contact Information online
from Celgene Corporation
POMALYST
US serial number:85150878
Application filling date:Oct. 12, 2010
Register:Principal
Mark type:Trademark
Status:Registered. The registration date is used to determine when post-registration maintenance documents are due.
Status date:Jun. 21, 2011
Publication date:Apr. 05, 2011
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Foreign priority claimed:Yes
Foreign foreign application number:60663/2010
Foreign foreign application filling date:Oct. 06, 2010
Foreign foreign registration number:606506
Foreign foreign registration date:Oct. 06, 2010
Foreign foreign application registration country:SWITZERLAND
Foreign foreign expiration date:Oct. 06, 2020
Goods and services:For: Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain cancers and blood diseases and printed dosage instructional manuals
Current owner owner name:Celgene Corporation
Current owner owner address:86 Morris Avenue
Summit,
NEW JERSEY
UNITED STATES
07901
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:Camille M. Miller
Attorney email:cmiller@cozen.com
Attorney docket number:276954/CELG0
Attorney email authorized:No
Correspondent name address:CAMILLE M. MILLER
COZEN O'CONNOR
1650 MARKET ST
One Liberty Place
PHILADELPHIA,
PENNSYLVANIA
UNITED STATES
19103-3527
Correspondent phone:2156657273
Correspondent email:cmiller@cozen.com
Correspondent fax:2157012273
Correspondent email authorized POMALYST:Yes
Latest trademarks
Popular owners
Glaxo Group Limited (174) Novartis AG (130) JOHNSON & JOHNSON (126) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Bristol-Myers Squibb Company (34) Forest Laboratories, Inc. (34) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Apr. 05, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Mar. 29, 2011 Nov. 16, 2010 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
